Where does GlaxoSmithKline Consumer Healthcare GmbH and Co. KG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), GlaxoSmithKline Consumer Healthcare GmbH and Co. KG ranks #31,778 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

What is GlaxoSmithKline Consumer Healthcare GmbH and Co. KG's Innovation Score?

GlaxoSmithKline Consumer Healthcare GmbH and Co. KG has an Innovation Score of 22.0 out of 100 (10th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does GlaxoSmithKline Consumer Healthcare GmbH and Co. KG focus on?

GlaxoSmithKline Consumer Healthcare GmbH and Co. KG's top technology area is A46B (Brushes) with 4 patents, ranking #71 of 322 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is GlaxoSmithKline Consumer Healthcare GmbH and Co. KG's patent grant rate increasing or decreasing?

GlaxoSmithKline Consumer Healthcare GmbH and Co. KG's recent grant velocity is -86% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for GlaxoSmithKline Consumer Healthcare GmbH and Co. KG's patents?

GlaxoSmithKline Consumer Healthcare GmbH and Co. KG's patents average 8.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

GlaxoSmithKline Consumer Healthcare GmbH and Co. KG

Q: How many patents does GlaxoSmithKline Consumer Healthcare GmbH and Co. KG hold?

GlaxoSmithKline Consumer Healthcare GmbH and Co. KG holds 8 US utility patents granted between 2015 and 2020, spanning 7 technology areas.

Q: How is the GlaxoSmithKline Consumer Healthcare GmbH and Co. KG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 8 granted patents across 7 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A46B (Brushes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Glaxosmithkline ranks #31,778 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 7 technology areas.

#31,778
of 49,997 US assignees by volume: 10th percentile
by Innovation Score (22.0/100): 8.5
avg claims per patent: -86%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31778 · Foreign Corporation #31,778 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #31,778/49,997
PHOTO-FINISH Gifu Plastic Industry
CPC-NARROW A46B · 7 areas
INNOV-THIN 22.0/100
CLAIMS-PAR 8.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -86% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gifu Plastic Industry Co. Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Glaxosmithkline’s 22.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (34%) Velocity 0.0 pts (0%) Breadth 9.4 pts (43%) Claim depth 5.1 pts (23%)

Qualcomm Incorporated · highest

85
GlaxoSmithKline… · this assignee

22
3D Lighting… · lowest

7

What this shows Glaxosmithkline's Innovation Score is 22.0/100 (10th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Glaxosmithkline?

Each dot is one of Glaxosmithkline’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Glaxosmithkline’s own 8.5 claims/patent is at or below the 10.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Glaxosmithkline vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Glaxosmithkline's grants concentrate

GlaxoSmithKline Consumer Healthcare GmbH and Co. KG is a focused PatentsView assignee: 7 CPC subclasses with 50% of grants classified under A46B (Brushes). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2016. By volume, Glaxosmithkline sits between Gifu Plastic Industry Co. Ltd. and GlySens Incorporated.

Gifu Plastic Indu…

8
Ginsey Industries

8
Giti Radial Tire…

8
Glam Labs

8
Glean

8
Global Algae Tech…

8
Global Energy Sci…

8
Glysens Incorpora…

8
Glaxosmithkline C… ◀

8

What this shows GlaxoSmithKline holds 8 patents at rank #31,812, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near GlaxoSmithKline

By rank, the assignees closest to #31,812 in granted patent volume.

Leaders in A46B (Brushes)

Other assignees with the most granted patents in GlaxoSmithKline's primary technology class.

Glaxosmithkline's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

22 10th percentile higher than 10% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

GlaxoSmithKline Consumer Healthcare GmbH and Co. KG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	25.0%
2016	1	12.5%
2017	2	25.0%
2018	2	25.0%
2020	1	12.5%

Which technologies does GlaxoSmithKline Consumer Healthcare GmbH and Co. KG patent most?

A46B - Brushes 4

A46D - Manufacture OF Brushes 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

A61C - DENTISTRY; Apparatus OR Methods FOR Oral OR Dental Hygiene 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

GlaxoSmithKline Consumer Healthcare GmbH and Co. KG's patent record in context - here's where to go next.

GlaxoSmithKline Consumer Healthcare GmbH and Co. KG's lead technology class is A46B (Brushes), 50% of its portfolio - see every assignee active in that class. Explore A46B
Ranked #31,778 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare GlaxoSmithKline Consumer Healthcare GmbH and Co. KG against Gifu Plastic Industry Co. Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 22.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.